Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Manag... (tive Officer. About Hypophosphatasia ...)

Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team

Date:9/22/2008

tive Officer.

About Hypophosphatasia

Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease. Patients have low levels of the tissue non-specific form of alkaline phosphatase, an important regulator of bone mineralization, leading to rickets in infants and children and osteomalacia ("soft bones" resulting from poor mineralization) in adults. Disease severity is inversely proportional to the age at symptom onset, but morbidity can be cumulative and worsen with age. Clinical severity ranges from the severe perinatal or infantile form, with profound skeletal hypomineralization and respiratory compromise often causing death, to a more slowly progressive and debilitating osteomalacia in adults.

In the infantile form, infants may appear normal at birth but develop serious symptoms in the first six months of life. These can include failure to thrive, respiratory failure, fractures, and seizures. Radiographic findings include generalized hypomineralization and rickets. Mortality in these patients may be as high as 50%. In the childhood form, patients have varying degrees of hypomineralization, frank rickets, short stature, bone pain, muscle weakness, delayed motor milestones, early loss of deciduous teeth, and may experience frequent, poorly-healing fractures. In the adult form, the underlying osteomalacia causes bone pain due to overt or poorly-healing stress fractures that in some cases stops ambulation.

About ENB-0040

ENB-0040 is a fusion protein that includes the catalytic domain of human tissue non-specific alkaline phosphatase (TNSALP), and a patented peptide used to target the enzyme to bone. Preclinical studies of ENB-0040 in the "knockout" mouse model of severe hypophosphatasia were recently published in the Journal of Bone and Mineral Research [June 2008:23:777-787] and showed that subcutaneous administration of ENB-0040 significantly improved survival and prevented the skeletal and dental manifestations
'/>"/>

SOURCE Enobia Pharma
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040
2. Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
3. Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
4. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
5. Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
6. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
7. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
8. VIA Pharmaceuticals to Present at American Heart Association Scientific Sessions 2008
9. Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer
10. Vanda Pharmaceuticals Provides Update on Iloperidone
11. Cerimon Pharmaceuticals Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain

Post Your Comments:

(Date:12/16/2009)... NASHVILLE, Tenn. , Dec. 16 ... medical cost management services, today commended two new ... from CT scans and other diagnostic imaging tests. ... essential to proper diagnosis and treatment," said Gregg ... these new studies offer more compelling evidence that ...

(Date:12/16/2009)... -- Wound Management Technologies, Inc. (OTC Bulletin ... specialty medical products, announced today that its ... productization of its patented orthopedic bone void ... to be introduced in Q3 2010, to ... multi-billion dollar international market. ,, "Resorbable Orthopedics ...

(Date:12/16/2009)... A new application developed ... clinical review of specialty pharmaceuticals has increased health ... reviewed while reducing costs. ,, AIM, a leading ... health plan clients representing over 35 million consumers ... WLP ), adapted the successful clinical ...

Breaking Medicine Technology:MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2 MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3 Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2 Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3 American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2 American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3 American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4 NCR Embeds DigitalPersona U are U 28R 29 4500HD Fingerprint Sensor in New NCR RealPOS 28TM 29 70XRT Point of Sale Workstations 10017 1 NCR Embeds DigitalPersona U are U 28R 29 4500HD Fingerprint Sensor in New NCR RealPOS 28TM 29 70XRT Point of Sale Workstations 10017 2 45 000 excess deaths annually linked to lack of health insurance 3A Harvard study 57890 1 45 000 excess deaths annually linked to lack of health insurance 3A Harvard study 57890 2 Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 1 Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 2 Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 3 Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 4

[0] MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure [0] Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics [0] American Imaging Management's New Specialty Drug Program Delivers Immediate Results

... Diabetes Therapy Also Improved Glucose ... Day, SAN FRANCISCO, June 9 Amylin Pharmaceuticals,Inc. ... LLY ), and Alkermes, Inc.,(Nasdaq: ALKS ) ... showed the durable efficacy of exenatide once weekly, a,long-acting ...

... long-term, large-scale and,independent studies evaluating cardiovascular (CV) outcomes ... 9,300 patients taking AVANDIA(R),(rosiglitazone maleate) and provide more ... The Veterans Affairs Diabetes Trial,(VADT), through two separate ... is no evidence to suggest that use of ...

After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R)

(Date:12/16/2009)... to disease , , WEDNESDAY, Dec. 16 (HealthDay News) ... leprosy have been identified by scientists in Singapore ... than 10,000 DNA samples from leprosy patients and ... the important role that the innate immune response ... leprosy is not common, the discoveries have significant ...

(Date:12/16/2009)... could help ease health and environmental concerns about the ... for changing the behavior of nanoparticles in municipal sewage ... Their study was published in ACS, journal Environmental ... UK Centre for Ecology and Hydrology and colleagues note ... nanoparticles particles less than 1/1000th the width of ...

(Date:12/16/2009)... Planet-Friendly Organics, Solar-Powered Manufacturing and Sustainable Packaging at an Affordable ... ... Angeles, CA (PRWEB) December 16, 2009 -- Actively healthy families ... all natural skin care for their children as Episencial ... featuring the beloved artwork of The Very Hungry Caterpillar from ...

(Date:12/16/2009)... caution, though, that no direct link has been found, ... bacteria in food -- commonly linked to food poisoning ... might also be the cause of some urinary tract ... the bacteria in chicken from stores and restaurants and ... evidence that the germs were transmitted directly to the ...

(Date:12/16/2009)... and MassBio promote Massachusetts companies through annual marketing campaign ... ... 2009 -- BioSpace unveiled the 2010 Genetown™ Hotbed Campaign ... , , , ,Genetown is sponsored by MassBio ... device industries. The campaign places each entity’s brand on an ...

Breaking Medicine News(10 mins):Health News:Leprosy Genes Identified 2 Health News:Behavior modification could ease concerns about nanoparticles 2 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 2 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 3 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 4 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 5 Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2 Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3 Health News:Thriving Bioscience Region Leaves Its Mark 2

[0] Leprosy Genes Identified [0] Behavior modification could ease concerns about nanoparticles [1] New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" [0] Foodborne E. Coli Suspected in Urinary Tract Infections [0] Thriving Bioscience Region Leaves Its Mark

... CHAPEL HILL, N.C., Sept. 13 "Profit, customers and,people ... the conference,Human Capital Management: Facing the Challenges of the ... taking care of your people, your people,will take care ... of your,business." At the recent HR-focused conference of ...

... now under development could enhance the design of sports ... sporting potential. , The models, more sophisticated and more ... produce unprecedentedly realistic simulations of how potential ball designs, ... , This data can then be harnessed by sports ...

... N.J., Sept. 12 The following is,a statement issued by ... CASSIDY, ON BEHALF OF ROSA ACUNA, RE: ... V. TURKISH, Today,s opinion is a stunning and surprising, ... Jersey. The opinion represents a,significant departure, in our judgment, from ...

... /PRNewswire-FirstCall/ - Transition Therapeutics Inc.,("Transition" or the ... developing therapeutics for disease indications,with large markets, ... year,ended June 30, 2007. Selected Highlights ... up to the date of this press ...

... EPI-Q, a leading healthcare,management consulting firm, announces today ... key appointment. EPI-Q, Inc. specializes in assisting life,sciences ... outcomes,and cost-effectiveness of patient care. Andrew Baker ... NY. Mr. Baker will have responsibility for global ...

... BEDFORD, Mass., Sept. 12 Hologic, ... of state-of-the-art diagnostic and,digital imaging systems directed ... statement, including a joint proxy,statement/prospectus, for a ... ), has become effective. The Company will ...

Broker a Suite of Research & Advisory Services to Enhance Human Resources Computer models help raise the bar for sporting achievement Historic Abortion Case; Acuna V. Turkish Transition Therapeutics Announces Fiscal 2007 Year End Financial Results EPI-Q Opens East Coast Office and Appoints Vice President-Business Development Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation

The TBR-360-1-GD is a large capacity upright style operating temperature +4C. It is specially designed refrigerators for the storage of blood in standard 500ml bags, complying with Australian Standar...

... precise requirements of blood banking and ... Equipment meets American Association of Blood ... (ANRC) and U.S. Food & Drug ... and platelet incubators feature alarm systems ...

Refrigerator specially designed for the storage of blood in standard 500ml bags, complying with Australian Standard AS3864 1997....

TBR-120-1-GD is large capacity upright style refrigerator with an operating temperature of +4C. It is a specially designed refrigerator for the storage of blood in standard 500ml bags, complying with...

Medicine Products:

Blood Storage Refrigerator TBR-360-1-GD Blood Bank Refrigerator 3626 Blood Storage Refrigerator TBR-160-1-GD Blood Storage Refrigerator TBR-120-1-GD

Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Manag...(tive Officer. About Hypophosphatasia ...),Health